¿Qué aporta prosigna en el tratamiento adyuvante de pacientes con cáncer de mama? - page 12

Validación prospectiva-retrospectiva del

Prosigna ROR en ABCSG08 y TRANSATAC

Gnant et al. Annals of oncology 2013

ABCSG08

N = 1478 pac

TAM vs TAM/ANASTROZOL

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,2,3,4,5,6,7,8,9,10,11 13,14,15,16,17,18,19,20,21,22,...24